[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530370":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":31,"locations":32,"responsibleParty":50,"collaborators":31,"id":53,"slug":31,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":31,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":31,"overallStatus":34,"whyStopped":31,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"conservation without the use of a tourniquet","PLACEBO_COMPARATOR","surgical conservation of placenta accreta spectrum cases with Kasr alainy conservative management technique, without the use of a tourniquet",[13],"Procedure: Conventional conservative surgery",{"label":15,"type":16,"description":17,"interventionNames":18},"conservation with the use of a tourniquet","ACTIVE_COMPARATOR","surgical conservation of placenta accreta spectrum cases with Kasr alainy conservative management technique, with the use of a uterovesical tourniquet before fetal extraction",[19],"Procedure: Uterovesical tourniquet before uterine devascularization steps",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Uterovesical tourniquet before uterine devascularization steps","Insertion of a Foley catheter tourniquet through broad ligament apertures \\& tightening it immediately before hysterotomy in cases of conservative management of placenta accreta spectrum",[15],[27],"Uterine Pringles maneuver",{"type":22,"name":29,"description":29,"armGroupLabels":30,"otherNames":31},"Conventional conservative surgery",[9],null,[33],{"facility":5,"status":34,"city":35,"state":31,"zip":31,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Cairo","Egypt","EG",{"type":39,"coordinates":40},"Point",[41,42],31.24967,30.06263,{"lat":42,"lon":41},[45],{"name":46,"role":47,"phone":48,"phoneExt":31,"email":49},"Abdalla Mousa","CONTACT","+201277664430","Dr_abdallamousa@yahoo.com",{"type":51,"investigatorFullName":46,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"PRINCIPAL_INVESTIGATOR","Lecturer of obgyn Cairo university","100530370",false,"NCT06185894","Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery","Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery (SPARTACUS) Study","SPARTACUS","Inclusion Criteria:\n\n* Pregnant females with previous CS deliveries (at least 1).\n* Patients with ultrasound criteria of placenta accerta spectrum.\n* Patients desiring fertility (uterine conservation).\n* Patients with gestational age that completed 34 weeks (or more) confirmed by the 1st day of the LMP or 1st trimester ultrasound scan.\n\nExclusion Criteria:\n\n* Maternal age above 40 years.\n* Chronic medical disorders (e.g., cardiac, renal, DM and hepatic diseases).\n* Patients presented with severe antepartum hemorrhage (unstable vital signs).\n* Patients requested radical management (caesarean hysterectomy).","FEMALE","20 Years","40 Years",{"count":64,"type":65},40,"ESTIMATED","INTERVENTIONAL",[68],"NA","Background: An optimal international standard for PAS surgery is not yet available, and the establishment of a suitable surgical method is an important focus of in PAS management.\n\nObjective: To assess the efficacy and safety of tourniquet uses for conservative approach in the management of placenta accerta spectrum.\n\nPatients and Methods: 40 pregnant women who underwent conservative management of placenta accrete at Kasr El-Aini hospital (Obstetrics and gynecology department - Faculty of medicine - Cairo university) were included and were divided according to the use of tourniquet into 2 equal groups: Study group (tourniquet group): consists of 20 women for whom tourniquet was used in the lower part of the uterus during surgical treatment of placenta accreta spectrum.Control group (no tourniquet group): consists of 20 women for whom no tourniquet was used.",[71],"Placenta Accreta","2024-06-01",{"date":74,"type":75},"2024-06-04","ACTUAL",{"date":77,"type":75},"2023-10-01",{"date":79,"type":65},"2024-06-30",{"name":5,"class":6},1]